Sotrovimab restores neutralization against current Omicron subvariants in patients with blood cancer

Wu et al. report that patients with hematologic malignancies have reduced immunity against SARS-CoV-2 Omicron subvariants and Sotrovimab retains neutralizing capacity against all tested Omicron subvariants.

Detalles Bibliográficos
Autores principales: Wu, Mary Y., Shepherd, Scott T.C., Fendler, Annika, Carr, Edward J., Au, Lewis, Harvey, Ruth, Dowgier, Giulia, Hobbs, Agnieszka, Herman, Lou S., Ragno, Martina, Adams, Lorin, Schmitt, Andreas M., Tippu, Zayd, Shum, Benjamin, Farag, Sheima, Rogiers, Aljosja, O’Reilly, Nicola, Bawumia, Philip, Smith, Callie, Carlyle, Eleanor, Edmonds, Kim, Del Rosario, Lyra, Lingard, Karla, Mangwende, Mary, Holt, Lucy, Ahmod, Hamid, Korteweg, Justine, Foley, Tara, Barber, Taja, Hepworth, Stephanie, Emslie-Henry, Andrea, Caulfield-Lynch, Niamh, Byrne, Fiona, Deng, Daqi, Williams, Bryan, Brown, Michael, Caidan, Simon, Gavrielides, Mike, MacRae, James I., Kelly, Gavin, Peat, Kema, Kelly, Denise, Murra, Aida, Kelly, Kayleigh, O’Flaherty, Molly, Popat, Sanjay, Yousaf, Nadia, Jhanji, Shaman, Tatham, Kate, Cunningham, David, Van As, Nicholas, Young, Kate, Furness, Andrew J.S., Pickering, Lisa, Beale, Rupert, Swanton, Charles, Gandhi, Sonia, Gamblin, Steve, Bauer, David L.V., Kassiotis, George, Howell, Michael, Walker, Susanna, Nicholson, Emma, Larkin, James, Wall, Emma C., Turajlic, Samra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2023
Materias:
Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10113515/
https://www.ncbi.nlm.nih.gov/pubmed/37116490
http://dx.doi.org/10.1016/j.ccell.2023.04.005

Ejemplares similares

Ejemplares similares